Dr Andrew Vaillant | Chief Scientific Officer
Replicor Inc.

Dr Andrew Vaillant, Chief Scientific Officer, Replicor Inc.

Dr. Vaillant is the Chief Scientific Officer at Replicor Inc.  He has more than 20 years of experience in the fields of nucleic acid chemistry, virology and drug development and is the discoverer of Replicor’s nucleic acid polymer (NAP) technology.  Dr. Vaillant has authored numerous primary publications and reviews on the use of NAPs in various infectious diseases focusing on HBV and HDV and the role of HBsAg loss and transaminase flares in achieving a functional cure of HBV.  He was a postdoctoral fellow at the Montreal Neurological Institute and holds a Ph.D. in Cell Biology from the University of Ottawa


WVIC/WAC Day 3 - Dec 1 @ 10:00

Chair’s opening remarks

WVIC/WAC Day 3 - Dec 1 @ 10:40

Subviral particle clearance and transaminase flares – roles in functional cure

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard


For sponsorship and exhibition opportunities:
Thomas Hall